CLINICAL TRIALS PROFILE FOR PORTIA-21
✉ Email this page to a colleague
All Clinical Trials for Portia-21
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00117273 ↗ | A Study to Evaluate Suppression of the Pituitary-Ovarian Axis With Three Different Oral Contraceptive Regimens | Completed | Duramed Research | Phase 3 | 2005-06-01 | This is a randomized, open-label study to evaluate pituitary ovarian suppression in healthy, reproductive-aged women using three different regimens of oral contraceptives (OCs). Two extended regimen OCs, Seasonale (levonorgestrel/ethinyl estradiol 0.15/0.03 mg for 84 days followed by 7 days of placebo), and Seasonique (levonorgestrel/ethinyl estradiol 0.15/0.03 mg for 84 days followed by 7 days of ethinyl estradiol 0.01 mg), and a 28-day regimen OC, Portia (levonorgestrel/ethinyl estradiol 0.15/0.03 mg for 21 days followed by 7 days of placebo). |
NCT00196365 ↗ | A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain | Completed | Duramed Research | Phase 3 | 2005-01-01 | This study is being conducted to evaluate the effects of treatment with Seasonique an extended-regimen oral contraceptive that utilizes low dose ethinyl estradiol during the typical hormone-free interval. Patients will receive 26 weeks of treatment. The overall study duration will be approximately 9 months. Patients will be required to record menstrual pain in a daily diary. |
NCT01170390 ↗ | Oral Contraceptives and Body Mass Index | Completed | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Phase 4 | 2009-09-01 | The main hypothesis for this study is that increased Body Mass Index (BMI) alters oral contraceptive metabolism in a manner which results in decreased effectiveness in obese women. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Portia-21
Condition Name
Clinical Trial Locations for Portia-21
Trials by Country
Clinical Trial Progress for Portia-21
Clinical Trial Phase
Clinical Trial Sponsors for Portia-21
Sponsor Name